889 assets in Neoplasm

Therapeutic assets addressing Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cldn6 Car-T Neoplasm	BioNTech Cell & Gene Therapies GmbH	P1	D (21)
Sail66 Neoplasm	Chugai Pharmaceutical	P1	D (21)
Zirconium Zr 89-Dfo-Ys5 Neoplasm	Robert Flavell, MD, PhD	P1	D (21)
Anti Alpp Car-T Cells Treatment Neoplasm	TCRCure Biopharma Ltd.	Early P1	D (20)
Cbp-1019 Neoplasm	M.D. Anderson Cancer Center	P1	D (20)
Enhanced Alpp Car-T Treatment Neoplasm	TCRCure Biopharma Ltd.	Early P1	D (20)
68Ga-NOTA-H006 Neoplasm	YiHui Guan	N/A	NR ()
68ga-sfb6-zn01 Neoplasm	Zhongnan Hospital	Early P1	NR ()
Acr-2316 Neoplasm	Acrivon Therapeutics	P1	NR ()
Atb-320 Neoplasm	Autotelicbio	P1	NR ()
bg-89894 Neoplasm	BeOne Medicines	P1	NR ()
Cci-001 Neoplasm	PharmaMatrix Holdings Ltd	P1	NR ()
e7386 Neoplasm	Eisai Inc.	P1/2	NR ()
Fg-B901 Neoplasm	FutureGen Biopharmaceutical (Beijing) Co., Ltd	P1/2	NR ()
gen1042 Neoplasm	Genmab	P1/2	NR ()
Hemay5087 Neoplasm	Ganzhou Hemay Pharmaceutical Co., Ltd	P1	NR ()
Hs-It201 Neoplasm	Qingdao Sino-Cell Biomedicine Co., Ltd.	Early P1	NR ()
ibi345 Neoplasm	Innovent Biologics (Suzhou) Co. Ltd.	P1	NR ()
ibi363 Neoplasm	Innovent Biologics (Suzhou) Co. Ltd.	P1	NR ()
Ivocizumab Neoplasm	Fudan University	P2	NR ()
Jskn016Hc Neoplasm	Jiangsu Alphamab Biopharmaceuticals Co., Ltd	P1	NR ()
Kivu-305 Neoplasm	Kivu Bioscience Inc.	P1	NR ()
Kst-6051 Neoplasm	Kestrel Therapeutics, Inc.	P1	NR ()
ky-0301 Neoplasm	Novatim Immune Therapeutics (Zhejiang) Co., Ltd.	P1/2	NR ()
Lrk-4189 Escalation Neoplasm	LARKSPUR BIOSCIENCES, INC.	P1/2	NR ()
Lrk-4189 Expansion Neoplasm	LARKSPUR BIOSCIENCES, INC.	P1/2	NR ()
Lrk-4189 Optimization Neoplasm	LARKSPUR BIOSCIENCES, INC.	P1/2	NR ()
Lutetium [177Lu]-Fap-75 Neoplasm	Fudan University	P1	NR ()
Met-4 Neoplasm	University Health Network, Toronto	P2/3	NR ()
Mst-168 Neoplasm	Mabsoft Therapeutics (Shanghai) Co., Ltd.	P1	NR ()
n17350 Neoplasm	Onchilles Pharma Inc	P1/2	NR ()
rc288 for Neoplasm	RemeGen Co., Ltd.	P1/2	NR ()
Shr-4685 Neoplasm	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P1	NR ()
sig001 Neoplasm	Peking University	P1	NR ()
Snh-118110 Soft Capsules Neoplasm	ScinnoHub Pharmaceutical Co., Ltd.	P1	NR ()
sy-9453 Neoplasm	Shouyao Holdings (Beijing) Co. LTD	P1	NR ()
Th-Cart-027 Neoplasm	Shanghai Tongji Hospital, Tongji University School of Medicine	Early P1	NR ()
Tumor Polypeptide Pool Induced Dc-Ctl Cell Neoplasm	Zhengzhou Revo-Gene Technology Co., LTD	N/A	NR ()
wtx212a Neoplasm	Zhejiang University	Early P1	NR ()

Showing 851 to 889 of 889 assets

PreviousPage 18 of 18Next